Shorted
Compumedics logo
CMP
Health Care Equipment & Services

Compumedics

Short interest
0.01%
−0.01 pp 30d
as of 22 Oct 2025
Reported shorts
10K
Shares on issue
192.218M

Compumedics (CMP) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$60.3M (source: ASX (Markit))vs $50.8M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
NPAT
$253.0K (source: ASX (Markit))vs −$1.3M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
EPS (diluted)
$0.001 (source: Derived: trailing 12 months at year end)vs −$0.007 (source: Derived: trailing 12 months at year end) (FY25)
Derived: trailing 12 months at year end, as at 14 Oct 2026
Rev YoY
+18.5%FY
EPS YoY
n/aTTM

EPS: prior loss, now profit (growth is not meaningful against a loss).

  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of Annual Report to shareholders, 30 Sep 2026

Compumedics reported record full-year revenue of $60.3m (up 18.5%), with a return to net profit of $0.3m (vs a loss of $1.3m in FY25). No dividend was declared. The company expects further double-digit revenue growth in FY27, with EBITDA growing faster than revenue.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026

Gross margin
51.4%
Operating margin
−0.7%
Net margin
0.4%
FCF margin
4.5%
ROE
n/a
ROA
n/a
FCF conversion
10.68×
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
−0.3×
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
218.2×
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

CMP income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$60.3M (source: ASX (Markit))$50.8M (source: ASX (Markit))$49.7M (source: ASX (Markit))$42.4M
Gross profit$31.0M (source: Derived: trailing 12 months at year end)n/an/a$21.6M
Operating income−$411.0K (source: Derived: trailing 12 months at year end)n/an/a−$4.5M
EBITDA$5.4M (source: Derived: trailing 12 months at year end)n/an/a−$5.1M
EBIT$3.2M (source: Derived: trailing 12 months at year end)n/an/a−$6.1M
Interest expense$1.5M (source: Derived: trailing 12 months at year end)n/an/a$652.0K
Pretax income$1.7M (source: Derived: trailing 12 months at year end)n/an/a−$6.7M
Tax$1.4M (source: Derived: trailing 12 months at year end)n/an/a−$597.0K
NPAT$253.0K (source: ASX (Markit))−$1.3M (source: ASX (Markit))−$338.0K (source: ASX (Markit))−$6.1M
Net interest income−$1.5M (source: Derived: trailing 12 months at year end)n/an/a−$652.0K
EPS basic$0.001 (source: Derived: trailing 12 months at year end)−$0.007 (source: Derived: trailing 12 months at year end)−$0.002 (source: Derived: trailing 12 months at year end)−$0.035
EPS diluted$0.001 (source: Derived: trailing 12 months at year end)−$0.007 (source: Derived: trailing 12 months at year end)−$0.010−$0.035
Sharesn/an/a177.2M177.2M
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Financial reports

The company's own filings, newest first